Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Poster Session 3

Category: Digital Health Technologies (DHT)

Poster Session 3

(846) Postpartum diabetes screening in patients with gestational diabetes enrolled in remote blood pressure monitoring

Thursday, February 12, 2026
10:30 AM - 12:00 PM  
Foundation Awardee
Objective:
Remote blood pressure monitoring (RBPM) in patients with hypertensive disorders of pregnancy (HDP) improves postpartum (PP) care engagement. We assessed whether RBPM participation improves PP screening (2-hour glucose tolerance test [2h GTT] and/or hemoglobin A1C [A1C]) for non-hypertensive disorders, such as gestational diabetes (GDM) and pre-gestational diabetes mellitus (DM).

Study Design:
Retrospective study of patients in PP RBPM program from 11/1/2022-6/30/2024. Patients with chronic hypertension or HDP are eligible for RBPM. Patients have telehealth visits for BP monitoring until they graduate (BP normalizes off medication or 12 weeks PP). Patients were grouped by RBPM engagement: 1) declined or enrolled but never attended; 2) attended ≥ 1 visit but did not graduate; 3) graduated. Patient characteristics and laboratory values were extracted from health records. Patient characteristics were compared by three groups; no diabetes, GDM and DM using chi-square or Fisher’s exact tests. We conducted sub-analyses of patients with GDM and DM. Primary outcomes were completion of 2h GTT by 12 weeks PP for GDM and A1C by 1 year for GDM and DM. Secondary outcome was time to A1C. Logistic regression determined the odds of the primary outcomes and ANOVA for secondary outcome.

Results:

1,160 patients were eligible for RBPM;165 had GDM and 120 had DM. Among GDM and DM patients,121(42.5%) were Group 1, 60 (23.3%) Group 2, 104(36.5%) Group 3. Of the 165 with GDM, 37(22.4%) completed 2h GTT; 9(14.5%), 5(15.6%) and 23(32.4%) in Group 1, 2 and 3 respectively. Odds of completing 2h GTT were significantly higher for RBPM graduates (Group 3 OR 2.82; 95% CI 1.19-6.69). No significant difference between partial and no engagement (Group 2 OR 1.09; 95% CI 0.33-3.58). No significant difference in odds of A1C completion for GDM or DM and no difference in time to A1C (Table 2).

Conclusion:
RBPM engagement improved DM screening within 12 weeks PP for GDM patients. While these patients may be more likely to complete recommended care, these findings suggest remote PP programs may improve PP care beyond HTN management.